CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for I'rom Group Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

I'rom Group Co Ltd
5F/6F
Iidabashi Grand Bloom, 2-10-2, Fujimi
Phone: +81 332643148p:+81 332643148 CHIYODA-KU, TKY  102-0071  Japan Ticker: 23722372
Business Summary
I'rom Group Co.,Ltd. is engaged in medical fields such as regenerative medicine and gene discovery. The Company operates through four business segments. The SMO segment provides support services for contracting or substituting a part of the work related to conducting clinical trials from the conducting medical institution. The CRO segment provides all or part of clinical trial operations from pharmaceutical companies and others. The Advanced Medicinal Treatment segment is engaged in the development of gene therapy products, the development, manufacture and sale of products in the field of regenerative medicine based on iPS cells related technologies, as well as the provision of contract manufacture services. The Medical Support segment provides general and comprehensive support for medical business management, such as setting up and renting clinic malls, selling products and related services. The Company also provides business utilizing IT infrastructure.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
8071 Medical laboratories
2834 Pharmaceutical preparations
5122 Drugs, drug proprietaries, and druggists' sundries
8731 Commercial physical and biological research
7359 Equipment rental and leasing, not elsewhere classified
8742 Management consulting services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, President of Subsidiaries, Representative Director ToyotakaMori 56 6/1/2019 6/28/2012
Vice President, Director ToshiyaHara 53 6/1/2021 6/1/2002
Vice President, Director MasaakiMatsushima 58 6/1/2022 6/28/2017
7 additional Officers and Directors records available in full report.

Business Names
Business Name
2372
CMAX
CMAX Clinical Research Pty Ltd.
I'rom Co., Ltd.
I'rom Holdings Co. Ltd.
NA Co., Ltd.

General Information
Number of Employees: 1,029 (As of 3/31/2024)
Outstanding Shares: 12,105,647 (As of 9/30/2024)
Shareholders: 7,341
Stock Exchange: TYO
Fax Number: +81 332643147


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, December 3, 2024